Is Vicryl (Polyglactin 910) suitable for facial suturing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vicryl Use on the Face for Wound Closure

Vicryl (polyglactin 910) can be used for facial suturing, but monofilament sutures (5-0 or 6-0) are generally preferred for facial skin closure due to less bacterial seeding, reduced infection risk, and minimal tissue reaction. 1

Considerations for Facial Suturing

Suture Material Selection

  • Preferred options for facial skin closure:
    • Monofilament sutures (5-0 or 6-0) are recommended as first-line for facial skin closure 1
    • Vicryl (polyglactin 910) is more appropriate for deep tissue layers rather than skin closure on the face
    • Rapidly absorbing synthetic sutures (like Vicryl Rapide) may be considered when suture removal would be challenging 1

Evidence for Vicryl in Facial Applications

  • Studies have shown that Vicryl can be used safely in facial areas:
    • 7-0 Vicryl and 7-0 Vicryl Rapide demonstrated excellent wound healing in ophthalmic plastic surgery with minimal tissue reaction 2
    • Vicryl Rapide (irradiated polyglactin 910) has shown good outcomes in oral and scalp wounds with no hypertrophic scarring 3

Tissue Reaction Considerations

  • Polyglactin 910 (Vicryl) elicits a foreign body inflammatory response proportional to suture gauge:
    • Larger gauge (5-0) produces significantly larger granuloma diameter compared to smaller gauge (7-0) 4
    • This inflammatory response may affect cosmetic outcomes, which is particularly important on the face

Suture Extrusion Risk

  • Vicryl (polyglactin 910) has shown higher extrusion rates (11.4%) compared to other absorbable sutures like poliglecaprone-25 (3.1%) 5
  • This higher extrusion rate could compromise cosmetic outcomes on the face

Best Practices for Facial Wound Closure

Layer-Specific Recommendations

  • Deep tissue layers:

    • Vicryl can be appropriately used for deep tissue closure with continuous non-locking sutures 1
    • Triclosan-coated Vicryl may be beneficial in higher-infection risk scenarios 6
  • Skin closure:

    • Monofilament sutures are preferred for facial skin closure
    • If using Vicryl for skin, consider smaller gauge (7-0) to minimize tissue reaction 4
    • Continuous subcuticular closure technique is recommended for improved cosmetic outcomes 1

Timing Considerations

  • Facial sutures typically require removal after 5-7 days 1
  • If using Vicryl Rapide, it eliminates the need for suture removal visits 1

Potential Pitfalls and Caveats

  • Vicryl may cause more tissue reaction than monofilament sutures, potentially affecting cosmetic outcomes on the face
  • Standard Vicryl requires removal if used for skin closure, unlike Vicryl Rapide
  • Facial wounds are highly visible, making optimal cosmetic outcome particularly important
  • Consider nerve block anesthesia for facial procedures as it may provide better anesthesia with less tissue distortion than infiltrative anesthesia 6

When choosing between Vicryl and other suture materials for facial closure, consider the specific wound characteristics, layer being closed, and the importance of cosmetic outcome in the particular facial region.

References

Guideline

Wound Closure and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of poliglecaprone-25 and polyglactin-910 in cutaneous surgery.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.